FDA Drug recall D-0182-2023
Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: P…
- FDA Drug
- Class I
- terminated
- Published 2023-02-01
On 2023-02-01 the FDA classified a Class I recall of Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: P… by Glaxosmithkline Consumer Healthcare Holdings, citing labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0182-2023 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-12-06 |
| Published | 2023-02-01 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Glaxosmithkline Consumer Healthcare Holdings |
| Distribution | US |
Product
Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3
Reason
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Identifiers
| upc | 305730169493 |
|---|---|
| code_info | Lot: R94065, Exp 02/29/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0182-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.